<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-039895</identifier>
<setSpec>0213-005X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Pseudomonas aeruginosa clonal dissemination in Brazilian intensive care units</dc:title>
<dc:description xml:lang="en">Objective. Investigate clonal dissemination of nosocomial multidrug-resistant Pseudomonas aeruginosa isolates within and between Brazilian intensive care units, which participated in the MYSTIC Program Brazil 2002. Methods. Thirty-six P. aeruginosa isolates resistant to meropenem or imipenem plus at least two of the following drugs: ciprofloxacin, cefepime, ceftazidime or piperacillin/tazobactam were isolated during 2002 at 4 centres in São Paulo and 1 centre in Brasília. Chromosomal restriction fragments obtained with SpeI were separated by pulsed-field gel electrophoresis (PFGE). Electrophoretic patterns were analyzed with GelCompar II v. 2.5.Results. Five major clones were identified (A, B, C, D, G). Clone A was constituted by 8 isolates with indistinguishable PFGE pattern present in 2 centres. Clone B was constituted by 4 indistinguishable isolates predominant in centre 6. Clone C had 3 indistinguishable isolates, with closely related clones (C1-3). Also, Clone D had 3 indistinguishable isolates, with closely related (D1) and possibly related (D2/D3) clones. Clones C and D were present in centre 1. Clone G was constituted by 2 indistinguishable isolates and was present in centre 7. Finally, 8 isolates were unique. Isolates from Centre 4 were unique. Conclusions. Clonal dissemination was detected within (clones A, B, C, D, and G) and between centres (clone A). These findings are important when analyzing surveillance data, since susceptibility rates may be significantly affected by the dissemination of a resistant clone (AU)</dc:description>
<dc:creator>Veiga-Kiffer, Carlos Roberto</dc:creator>
<dc:creator>Mello-Sampaio, Jorge Luiz</dc:creator>
<dc:creator>Turner, Philip</dc:creator>
<dc:creator>Sinto, Sumiko</dc:creator>
<dc:creator>Oplustil, Carmen Paz</dc:creator>
<dc:creator>Cardoso-Leão, Sylvia</dc:creator>
<dc:creator>Figueiredo-Mendes, Caio Marcio</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo. Investigar la diseminación clonal de cepas nosocomiales multirresistentes de Pseudomonas aeruginosa en y entre unidades de cuidados intensivos brasileñas participantes en el MYSTIC Program Brazil 2002.Métodos. Durante 2002, se aislaron en cuatro hospitales de São Paulo y en un hospital de Brasilia 36 cepas de P. aeruginosa resistentes a meropenem o imipenem y a al menos dos de los siguientes: ciprofloxacino, cefepima, ceftazidima o piperacilina/tazobactam. Los fragmentos de restricción cromosómica obtenidos mediante Spel se separaron con electroforesis en campo pulsado (PFGE) y se analizaron mediante GelCompar II v.2.5. Resultados. Se identificaron cinco clones principales (A, B, C, D y G). El clon A constaba de ocho cepas con un patrón PFGE indistinguible, aisladas en dos centros. El clon B estaba formado por cuatro cepas indistinguibles, predominantes en el centro 6. El clon C estaba formado por tres cepas indistinguibles con clones estrechamente relacionados (C1-3). Además, el clon D estaba formado por tres cepas indistinguibles con clones estrechamente (D1) o posiblemente relacionados (D2/D3). Los clones C y D se detectaron en el centro 1. El clon G estaba formado por dos cepas indistinguibles y se observó en el centro 7. Finalmente, ocho cepas fueron específicas. Las cepas del centro 4 fueron específicas. Conclusiones. Se detectó diseminación clonal en los propios centros (clones A, B, C, D y G) y entre centros (clon A). Estos hallazgos son importantes para evaluar los datos de vigilancia epidemiológica pues la diseminación de un clon resistente puede influir de manera significativa en las tasas de sensibilidad (AU)</dc:description>
<dc:source>Enferm Infecc Microbiol Clin;23(7): 402-405, ago. 2005. ilus, tab</dc:source>
<dc:identifier>ibc-039895</dc:identifier>
<dc:title xml:lang="es">Diseminación clonal de Pseudomonas aeruginosa en unidades de cuidados intensivos brasileñas</dc:title>
<dc:subject>^d1963^s22080</dc:subject>
<dc:subject>^d28477^s22046</dc:subject>
<dc:subject>^d11989^s22046</dc:subject>
<dc:subject>^d11989^s22080</dc:subject>
<dc:subject>^d911^s22078</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d36323^s22033</dc:subject>
<dc:subject>^d28477^s22080</dc:subject>
<dc:subject>^d24244</dc:subject>
<dc:subject>^d30142</dc:subject>
<dc:subject>^d11988^s22021</dc:subject>
<dc:type>article</dc:type>
<dc:date>200508</dc:date>
</metadata>
</record>
</ibecs-document>
